Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03605303 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process
A NA study, sponsored by Johnson & Johnson Vision Care.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03605303: Clinical Trial NA study, sponsored by Johnson & Johnson Vision Care.
NCT03605303 is a NA study that was terminated before completion, run by Johnson & Johnson Vision Care. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03605303, a NA study, was terminated before completion, sponsored by Johnson & Johnson Vision Care.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Primary Outcome
Subjective assessment of comfort will be performed using the Contact Lens User ExperienceTM (CLUE) questionnaire. CLUE is a validated patient reported outcomes (PRO) questionnaire used to assess patient experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a US contact-lens wearing population between 18 and 65 years of age. CLUE composite scores are derived using Item Response Theory (IRT) and follow a normal distribution with a population average score of 60
Interventions
- DEVICE Test/Control
- DEVICE Control/Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2018-07-05 |
| Phase | NA |
Why NCT03605303 stopped before completion
NCT03605303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Test/Control is the first listed.
NCT03605303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03605303 about?
NCT03605303 is a clinical study titled "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process". This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the ...
What is the current status of trial NCT03605303?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-07-03. Estimated completion is 2018-07-05.
What interventions are being tested in trial NCT03605303?
The interventions under investigation include: Test/Control (DEVICE), Control/Test (DEVICE).
Who is sponsoring clinical trial NCT03605303?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03605303's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI